TNPSC Thervupettagam

Cancer Drug Trial – Dostarlimab

June 15 , 2022 926 days 1293 0
  • A trial of a drug for cancer treatment has shown 100% success in removing the tumours and preventing recurrence in patients.
  • A trial was held in Manhattan, USA.
  • The medication aimed to unmask cancer cells, allowing the body’s immune system to identify and destroy them naturally.
  • Such drugs, known as ‘checkpoint inhibitors.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories